{
    "Trade/Device Name(s)": [
        "PF4 ENHANCED\u00ae Solid Phase ELISA",
        "PF4 ENHANCED\u00ae"
    ],
    "Submitter Information": "Genetic Testing Institute, Inc. (GTI)",
    "510(k) Number": "K053559",
    "Predicate Device Reference 510(k) Number(s)": [
        "K983379"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LCO",
        "0545"
    ],
    "Summary Letter Date": "December 19, 2005",
    "Summary Letter Received Date": "December 21, 2005",
    "Submission Date": "",
    "Regulation Number(s)": [
        "21CFR864.7695"
    ],
    "Regulation Name(s)": [
        "Platelet factor 4 radioimmunoassay"
    ],
    "Analyte Class(es)": [
        "immunology",
        "hematology",
        "coagulation"
    ],
    "Analyte(s)": [
        "Antibodies reactive with platelet factor 4 (PF4) complexed to polyanionic compounds such as Polyvinyl Sulfonate (PVS)",
        "Heparin-associated antibodies"
    ],
    "Specimen Type(s)": [
        "Serum"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "Spectrophotometer"
    ],
    "Method(s)/Technology(ies)": [
        "Enzyme-linked immunosorbent assay (ELISA)",
        "Optical density detection"
    ],
    "Methodologies": [
        "Solid phase ELISA"
    ],
    "Submission Type(s)": [
        "Assay",
        "Kit"
    ],
    "Document Summary": "FDA 510(k) summary for PF4 ENHANCED\u00ae Solid Phase ELISA to qualitatively detect antibodies associated with heparin induced thrombocytopenia (Type II HIT)",
    "Indications for Use Summary": "Intended as an in vitro diagnostic kit to assist laboratories in screening patient samples for the presence of heparin-associated antibodies commonly found in patients with heparin induced thrombocytopenia or thrombosis",
    "fda_folder": "Hematology"
}